163 related articles for article (PubMed ID: 26255620)
21. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858
[TBL] [Abstract][Full Text] [Related]
23. Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.
da Silva PM
Am J Cardiovasc Drugs; 2011; 11(2):93-107. PubMed ID: 21446776
[TBL] [Abstract][Full Text] [Related]
24. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
25. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
Hafiane A; Jabor B; Ruel I; Ling J; Genest J
Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
[TBL] [Abstract][Full Text] [Related]
27. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
[TBL] [Abstract][Full Text] [Related]
28. High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?
Uzunlulu M; Oğuz A; Tigen K
Anadolu Kardiyol Derg; 2005 Dec; 5(4):268-70. PubMed ID: 16330390
[TBL] [Abstract][Full Text] [Related]
29. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
Sachdeva A; Cannon CP; Deedwania PC; Labresh KA; Smith SC; Dai D; Hernandez A; Fonarow GC
Am Heart J; 2009 Jan; 157(1):111-117.e2. PubMed ID: 19081406
[TBL] [Abstract][Full Text] [Related]
30. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
[TBL] [Abstract][Full Text] [Related]
31. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
[TBL] [Abstract][Full Text] [Related]
32. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
33. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients.
Tseng CH; Tseng CP; Chong CK; Cheng JC; Tai TY
Int J Cardiol; 2006 Jul; 111(1):80-5. PubMed ID: 16213608
[TBL] [Abstract][Full Text] [Related]
34. Low-density lipoprotein cholesterol/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study.
Tani S; Saito Y; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Nagao K; Hirayama A
Int Heart J; 2011; 52(6):343-7. PubMed ID: 22188706
[TBL] [Abstract][Full Text] [Related]
35. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
[TBL] [Abstract][Full Text] [Related]
36. Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.
Toyama K; Sugiyama S; Oka H; Iwasaki Y; Sumida H; Tanaka T; Tayama S; Jinnouchi H; Matsui K; Ogawa H
Atherosclerosis; 2011 Jul; 217(1):158-64. PubMed ID: 21458815
[TBL] [Abstract][Full Text] [Related]
37. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K;
Atherosclerosis; 2008 Sep; 200(1):135-40. PubMed ID: 18667204
[TBL] [Abstract][Full Text] [Related]
38. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.
Ray KK; Ditmarsch M; Kallend D; Niesor EJ; Suchankova G; Upmanyu R; Anzures-Cabrera J; Lehnert V; Pauly-Evers M; Holme I; Štásek J; van Hessen MW; Jones P;
Eur Heart J; 2014 Jul; 35(27):1792-800. PubMed ID: 24639426
[TBL] [Abstract][Full Text] [Related]
39. [Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl].
Arteaga A; Martínez A; Pollak F; Borghesi L; Catalán L; Acosta AM; Leighton F
Rev Med Chil; 1995 Feb; 123(2):145-57. PubMed ID: 7569454
[TBL] [Abstract][Full Text] [Related]
40. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
Alwaili K; Bailey D; Awan Z; Bailey SD; Ruel I; Hafiane A; Krimbou L; Laboissiere S; Genest J
Biochim Biophys Acta; 2012 Mar; 1821(3):405-15. PubMed ID: 21840418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
